TCTR20220712005Unknown2 期
Efficacy and safety of hypromellose-based nasal solution spray containing human IgG1 anti-SARS-CoV-2 antibody in high-risk close contact COVID-19: A doubled-blind, randomized, placebo controlled trial
/A0 个研究点目标入组 1,000 人开始时间: 2022年7月12日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Age > 18 years
- •2. High risk or close contact with COVID-19 infection patient within 72 hours
- •3. Result of ATK Lysun COVID-19 Antigen Rapid Test Device (Colloidal Gold) is negative on enrollment day
- •4. No history of COVID-19 infection within 3 months
- •5. Sign inform consent form
排除标准
- •1. Pregnancy
- •2. Unacceptable to sign inform consent form
- •3. History of sever allergic reaction to component of VaillTM CoViTRAP
研究者
相似试验
尚未招募
2 期
Application of human milk into nose for brain protection in babies who fail to breathe at birthCTRI/2023/08/056505Banaras Hindu University
招募中
2 期
Application of human milk into Nose for brain protection in premature babiesCTRI/2023/01/049335Banaras Hindu University
招募中
1 期
A study on safety and efficacy of high-flow nasal cannula attachable hydrogen gas generator for ARDSJPRN-jRCTs062220003akao Atsunori40
尚未招募
2 期
asal inhaler in Common coldCTRI/2021/08/035577Rishicul Campus Uttarakhand Ayurveda Haridwar
进行中（未招募）
不适用
Efficacy of intranasal administration of haloperidol compared to intramuscular administration in agitated schizophrenic patientsEUCTR2014-001157-17-ESFundació Parc Taulí40